Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
PLTR$172.26-6.10(-3.42%)Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher11:31:59 AM ETETOLF$1.230.00(0.00%)Enterprise Products Covers Its Distribution 1.9 Times. Here Are 3 More High-Yield Stocks11:17:28 AM ETPFE$30.48-0.22(-0.72%)PFE Beats Q3 Earnings & Sales Estimates, Raises 2026 Guidance11:16:08 AM ETSHOP$145.05-11.15(-7.14%)Shopify president Harley Finkelstein: Shopping through AI channels is 'growing quite quickly'11:09:07 AM ETPLTR$172.26-6.10(-3.42%)U.S. Companies Now Pay Palantir More Than the U.S. Government for the First Time11:07:13 AM ETPLTR$172.26-6.10(-3.42%)Palantir's CEO on Q3 results and boom in company's commercial business11:06:12 AM ETJPM$336.70-3.94(-1.16%)JPM Opens Dubai Private Banking Branch: Will Wealth Revenues Grow?11:06:05 AM ETNVDA$207.77+5.57(+2.75%)Nvidia up over 3%: what's driving Tuesday's rally?11:05:30 AM ETABBV$288.90+0.02(+0.01%)AbbVie Hit a New High After Earnings. There's More Upside Left.11:03:57 AM ETAAPL$331.55-7.04(-2.08%)AAPL Q4 Earnings Call Highlights Supply Risks and AI Investment11:01:45 AM ETSPCX$140.15+3.81(+2.79%)SpaceX Q3 Earnings Call Highlights Aggressive AI Compute Expansion11:01:21 AM ETPLTR$172.26-6.10(-3.42%)"Phenomenal" PLTR Earnings Meet Tech Slowdown: Stock Faces AI & Technical Headwinds11:00:05 AM ETSPCX$140.15+3.81(+2.79%)Why Anthropic's IPO May Have Just Gotten a Whole Lot Riskier11:00:02 AM ETSPCX$140.15+3.81(+2.79%)SpaceX Just Delivered a Monster Quarter, but the Stock Is Still Down 38% From Its High. The Reasons Are Obvious.11:00:00 AM ETTSM$405.00+6.56(+1.65%)Taiwan Semi or Broadcom: If I Could Only Own 1 for the Next 5 Years, It Would Be This11:00:00 AM ETCRWD$245.51+3.73(+1.54%)CrowdStrike Is Preparing for an AI Threat That Could Already Be Inside the Company10:55:03 AM ETTSLA$398.09-5.77(-1.43%)QUICK SPARK: Elon Musk Says 'Vote Red' — SpaceX And Tesla Have Much To Gain10:53:51 AM ETPFE$30.48-0.22(-0.72%)UPDATE 4-Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results10:52:11 AM ETDIS$113.18+0.04(+0.04%)Disney's Cost-Cutting Push Could Put Its Stock Rally to the Test10:51:00 AM ETAAPL$331.55-7.04(-2.08%)Apple shares fall despite profit growth as traders fear rising chip costs10:49:02 AM ETCRM$222.42-3.68(-1.63%)The Selloff Didn't Stop Salesforce From Spending $2.7 Billion on an AI Startup10:48:10 AM ETETOLF$1.230.00(0.00%)Super Micro Climbs 4% Ahead of Earnings as AI Server Stocks Bounce; Hewlett Packard Enterprise Rallies 6%, Dell Gains 5%10:47:51 AM ETCOP$144.15-2.70(-1.84%)Why ConocoPhillips (COP) is a Top Growth Stock for the Long-Term10:46:33 AM ETTSM$405.00+6.56(+1.65%)Until Next Gen Computing Implodes I'll Keep Buying Taiwan Semiconductor10:45:30 AM ET

SOPH · NASDAQ

SOPHiA GENETICS S.A.

$7.09 -0.03 (-0.42%)

Company overview

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers the SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. The SOPHiA DDM platform and related solutions, products, and services are used by hospitals, laboratories, and biopharma companies worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$604M
Employees
423
Headquarters
Rolle
Website
sophiagenetics.com
CEO
Jurgi Camblong
Listed
July 23, 2021
P/E
-6.01
Dividend yield
0.00%

Company financials

Revenue
$81.2M
Gross profit
$54.6M
Operating income
-$71.8M
EBITDA
-$66.1M
Net income
-$80.9M
EPS
-$1.18
Total assets
$157M
Total debt
$62.4M
Gross margin
67.28%
Net margin
-99.70%
Earnings yield
-16.64%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

4.265.496.717.949.16
SOPH 1D NASDAQ O7.52H7.60L7.03C7.12-0.51 (-6.75%)Vol300.09K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS Q3 Earnings Call Highlights MarketBeat
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Beats Revenue Estimates Zacks Investment Research
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS Reports Third Quarter 2026 Results PR Newswire
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026 SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third... PR Newswire
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? Zacks Investment Research
SOPHSOPHiA GENETICS S.A. Stock news When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals MarketBeat
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript Seeking Alpha
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS Q2 Earnings Call Highlights MarketBeat
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS Reports Second Quarter 2026 Results PRNewsWire
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies PRNewsWire
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PRNewsWire
SOPHSOPHiA GENETICS S.A. Stock news This Crane Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Benzinga
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center PRNewsWire
SOPHSOPHiA GENETICS S.A. Stock news Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. GuruFocus
SOPHSOPHiA GENETICS S.A. Press release Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. PRNewsWire
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript Seeking Alpha
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS Reports First Quarter 2026 Results PRNewsWire
SOPHSOPHiA GENETICS S.A. Press release SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 PRNewsWire
SOPHSOPHiA GENETICS S.A. Press release Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 PRNewsWire
SOPHSOPHiA GENETICS S.A. Stock news SOPHiA GENETICS (NASDAQ:SOPH) & Hims & Hers Health (NYSE:HIMS) Financial Comparison Defense World
See more
FAQ

Questions about SOPHiA GENETICS S.A.

What does SOPHiA GENETICS S.A. do?
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers the SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. The SOPHiA DDM platform and related solutions, products, and services are used by hospitals, laboratories, and biopharma companies worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
What is SOPH's market cap?
SOPHiA GENETICS S.A. (SOPH) is a listed stock with a live quote. The latest market cap on this page is $604M.
Where is SOPHiA GENETICS S.A. headquartered?
SOPHiA GENETICS S.A. is headquartered in Rolle.
How do I get SOPH news from the API?
Call GET /v1/news?tickers=SOPH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does SOPH news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SOPH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the SOPH price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs